Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New page revision tag added: v3.5.4, indicating a recent update to the study details page. This revision is a backend/content update and does not modify the study data or displayed information.
    Difference
    0.1%
    Check dated 2026-05-14T23:22:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision history on the study page was updated to add revision v3.5.3 and remove v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-30T14:21:27.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to the study details or page layout.
    Difference
    0.1%
    Check dated 2026-04-16T10:25:32.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This update appears to be a system/UI refresh and does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-03-25T20:40:24.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:39:23.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The study status is updated to terminated due to financial hardships, and results have been posted with dates and linked documents. The prior Active, not recruiting status and earlier submission notes were removed.
    Difference
    2%
    Check dated 2026-02-18T06:58:44.000Z thumbnail image

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.